|
|
Blood, 15 May 2005, Vol. 105, No. 10, pp. 3918-3924.
Prepublished online as a Blood First Edition Paper on February 8, 2005; DOI 10.1182/blood-2004-09-3689.
Previous Article | Next Article 
Submitted September 23, 2004
Accepted January 17, 2005
Rapid ubiquitination of Syk following GPVI activation in platelets
Carol A Dangelmaier, Patricia G Quinter, Jianguo Jin, Alexander Y Tsygankov, Satya P Kunapuli, and James L Daniel*
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA, USA
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Center, Temple University School of Medicine, Philadelphia, PA, USA
Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA; Sol Sherry Thrombosis Center, Temple University School of Medicine, Philadelphia, PA, USA
* Corresponding author; email: jdaniel{at}temple.edu.
Syk activation is a key intermediate step in the activation of platelets by the physiologic agonist collagen. We have found that Syk is rapidly ubiquitinated upon activation of platelets by collagen, CRP and convulxin. The Src family kinase inhibitors prevented Syk phosphorylation and its ubiquitination, indicating that the process is downstream of Src kinases. The ubiquitination of Syk did not cause degradation of the protein as evidenced by the lack of effect of proteasomal and lysosomal inhibitors. We separated ubiquitinated Syk from its non-ubiquitinated counterpart and used an in vitro kinase assay to compare their activities. We found that the ubiquitinated Syk appeared to be about five-fold more active. Using a phosphospecific antibody to Syk (Tyr525/Tyr526) that measures activated Syk, we found that the majority (60-75%) of the active Syk is in the ubiquitinated fraction. This result explains the apparent high specific activity of ubiquitinated Syk. In c-Cbl deficient mice, Syk is not ubiquitinated implicating c-Cbl as the E3 ligase involved in Syk ubiquitination. Furthermore, Syk is not dephosphorylated in these mice. We propose that c-Cbl plays a regulatory role in GPVI/FcR[[gamma]-chain-dependent platelet activation through its interaction with Syk.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Nakao, K. Hirasaka, J. Goto, K. Ishidoh, C. Yamada, A. Ohno, Y. Okumura, I. Nonaka, K. Yasutomo, K. M. Baldwin, et al.
Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading
Mol. Cell. Biol.,
September 1, 2009;
29(17):
4798 - 4811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Bynagari, B. Nagy Jr., F. Tuluc, K. Bhavaraju, S. Kim, K. V. Vijayan, and S. P. Kunapuli
Mechanism of Activation and Functional Role of Protein Kinase C{eta} in Human Platelets
J. Biol. Chem.,
May 15, 2009;
284(20):
13413 - 13421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, L. Simeoni, J. A. Lindquist, J. Saez-Rodriguez, A. Ambach, E. D. Gilles, S. Kliche, and B. Schraven
Dynamics of Proximal Signaling Events after TCR/CD8-Mediated Induction of Proliferation or Apoptosis in Mature CD8+ T Cells
J. Immunol.,
May 15, 2008;
180(10):
6703 - 6712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. A. Karim, W. Choi, and S. W. Whiteheart
Primary Platelet Signaling Cascades and Integrin-mediated Signaling Control ADP-ribosylation Factor (Arf) 6-GTP Levels during Platelet Activation and Aggregation
J. Biol. Chem.,
May 2, 2008;
283(18):
11995 - 12003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rabie, D. Varga-Szabo, M. Bender, R. Pozgaj, F. Lanza, T. Saito, S. P. Watson, and B. Nieswandt
Diverging signaling events control the pathway of GPVI down-regulation in vivo
Blood,
July 15, 2007;
110(2):
529 - 535.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|